drugIndia
Cart
Hmet Trio 2 Tablet SR

Hmet Trio 2 Tablet SR

Voglibose (0.2mg) + Glimepiride (2mg) + Metformin (500mg)

Jarun Pharmaceuticals
Epilepsy
132.00165.0020% OFF
In Stock
1
Safe & Secure
Easy Returns
24/7 Support
Delivery
drugIndia verified
Save 67%
Best Alternative100% Match

Ozomet-VG2 Tablet SR

Ozone Pharmaceuticals Ltd

Voglibose 0.2mg
Ozomet-VG2 Tablet SR

Pack Size

1 units

Price

43.8420% off
Ozomet-VG2 Tablet SR is 100% same as Hmet Trio 2 Tablet SR
Better ValueSame QualitySame Effectiveness

Save ₹88

that's 67% off!

composition
  1. Voglibose 0.2mg
  2. Glimepiride 2mg
  3. Metformin 500mg
Buy Now
132.0020% OFF
165.00

About This Medicine

Product description & overview

HMET Trio 2 Tablet SR: A Comprehensive Approach to Blood Sugar Management

Hmet Trio 2 Tablet SR is a once-daily tablet containing a unique combination of three medications: Glimepiride (2mg), Metformin (500mg), and Voglibose (0.2mg). These active ingredients work synergistically to effectively manage blood glucose levels in adults with type 2 diabetes.

* Glimepiride: A sulfonylurea medication that stimulates insulin release from the pancreas.
* Metformin: A biguanide that reduces hepatic glucose production and improves insulin sensitivity.
* Voglibose: A glucosidase inhibitor that slows down the absorption of sugar in the gut, further aiding blood glucose control.

Hmet Trio 2 Tablet SR offers a convenient and comprehensive solution for individuals managing their blood sugar levels with a single daily dosage. This combination medication provides a powerful approach to achieving optimal glycemic control and reducing the risk of complications associated with diabetes. Always consult your healthcare provider before starting any new medication regimen.

Please note: This information is not intended as medical advice. Always read the full product label and consult your doctor for personalized guidance on blood sugar management.

Active composition

Voglibose 0.2 mg

+2 more active ingredients

About Voglibose

Voglibose is an alpha-glucosidase inhibitor used to manage type 2 diabetes by preventing carbohydrate absorption in the intestines. It helps control post-meal blood sugar spikes and is often used in conjunction with diet and exercise. In summary, it aids in effective diabetes management.

How It Works

Voglibose inhibits intestinal alpha-glucosidases, delaying carbohydrate digestion and absorption, thus lowering postprandial glucose levels.

Medicine Strength
0.2 mg

All Active Ingredients

Voglibose0.2 mg
Glimepiride2 mg
Metformin500 mg

Glimepiride

Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.

Metformin

Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.

Dosage & How to Use

Dosage information not available. Please consult your doctor or pharmacist.

Safety Advice

Important precautions

Side Effect Occurrence

Based on clinical trials and patient reports.

Overall Tolerance

Most patients tolerate well

Only 2.3% reported effects

Common Side Effects

Headache8%
Nausea5%
Dizziness3%
Fatigue2%
Rash1%
Higher
Lower

Safety Advice

Alcohol

It is unsafe to consume alcohol with Hmet Trio 2 Tablet SR.

High Risk

Pregnancy

Hmet Trio 2 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Medical Advice

Driving

Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.

Exercise Caution

Liver

Hmet Trio 2 Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Hmet Trio 2 Tablet SR may be needed. Please consult your doctor. Hmet Trio 2 Tablet SR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.

Regular Checkup

Breastfeeding

Hmet Trio 2 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

Consult Doctor

Kidney

Hmet Trio 2 Tablet SR is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor. Use of Hmet Trio 2 Tablet SR is, however, not recommended in patients with severe kidney disease.

Regular Checkup

Customer Reviews

0 reviews for Hmet Trio 2 Tablet SR

Products matching your search